In this issue we are presenting another installment of our quarterly review of dealmaking—in this case January to March 2002. Our data comes from Windhover's Strategic Transactions Database, which covers the deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
Some notes about our coverage: we limit our review to human health care (thus no animal health or agricultural transactions);...